SIBLING GROUP HOLDINGS INC Inactive Instrument
Sibling Group Holdings Inc Stock Other OTC
Equities
US8257821053
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2023 | EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million. | CI |
| 2023 | Drazcanna, Inc. Announces CEO Changes | CI |
Financials (USD)
| Sales 2014 | 0.15 | Sales 2015 | 2.21 | Capitalization | 12.15M |
|---|---|---|---|---|---|
| Net income 2014 | -1M | Net income 2015 | -7M | EV / Sales 2014 | 26,727,146 x |
| Net Debt 2014 | 110K | Net cash position 2015 | 5.29M | EV / Sales 2015 | 3,109,835 x |
| P/E ratio 2014 |
-1.83
x | P/E ratio 2015 |
-0.74
x | Employees | - |
| Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 94.26% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
Hussein A. Anani
CEO | Chief Executive Officer | - | 20-12-31 |
Mouktar Makkouk
DFI | Director of Finance/CFO | - | 23-09-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.09% | 43.84B | |
| +46.85% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
